Drugmakers Join to Pledge No Safety Shortcuts for Covid Vaccine
In this article
Sign up here for our daily coronavirus newsletter on what you need to know, andsubscribe to our Covid-19 podcast for the latest news and analysis.
Drugmakers racing to produce Covid-19 vaccines pledged to avoid shortcuts on science as they face pressure to rush a shot to market.
In an unusualpublic letter, the companies agreed to submit the vaccines for clearance only when they’re shown to be safe and effective in large clinical studies. The chief executive officers of nine frontrunners in the push for a coronavirus inoculation signed the pledge:AstraZeneca Plc,BioNTech SE,GlaxoSmithKline Plc,Johnson & Johnson,Merck & Co.,Moderna Inc.,Novavax Inc.,Pfizer Inc. andSanofi.
“In the interest of public health, we pledge to always make the safety and well-being of vaccinated individuals our top priority,” the executives wrote.
75,809 in IndiaMost new cases today
+0% Change in MSCI World Index of global stocks since Wuhan lockdown, Jan. 23
-1.026 Change in U.S. treasury bond yield since Wuhan lockdown, Jan. 23
5.3% Global GDP Tracker (annualized), Aug.